StockData
Tenax Therapeutics, Inc. logo

Tenax Therapeutics, Inc. (TENX) income statement

TENXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30
$1.25−0.14 (-10.07%)

Close on Nov 20, 2026Market cap $46.78MP/E –Yield –

See a number that looks wrong?